Sodium valproate for epilepsy in rural China: An efficacy and safety assessment in primary care
Authors:
- Wenzhi WangWWWenzhi Wang
- Jianzhong WuJWJianzhong Wu
- Shichuo LiSLShichuo Li
- Xiaojuan RuXRXiaojuan Ru
- Jinou ZhengJZJinou Zheng
- Suiqiang ZhuSZSuiqiang Zhu
- Josemir W. SanderJSJosemir W. Sander
- 1 December 2012
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 102 (3) , 201-205
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Causes of death among people with convulsive epilepsy in rural West ChinaNeurology, 2011
- Oral valproic acid for epilepsy - long-term experience in therapy and side effectsExpert Opinion on Pharmacotherapy, 2008
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Premature mortality in people with epilepsy in rural China: a prospective studyThe Lancet Neurology, 2006
- Role of valproate across the ages. Treatment of epilepsy in childrenActa Neurologica Scandinavica, 2006
- The natural history of epilepsy: an epidemiological viewJournal of Neurology, Neurosurgery & Psychiatry, 2004
- The Treatment Gap in Epilepsy: The Current Situation and Ways ForwardEpilepsia, 2001
- Safety and Efficacy of Divalproex Sodium Monotherapy in Partial EpilepsyNeurology, 1997
- Valproic AcidDrugs, 1994
- Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performancesEpilepsy Research, 1992